Table 3: Clinical outcomes.

Before PS matchingAfter PS matching
Variablede novo≤ 2.75 mm>2.75 mmp-value≤ 2.75 mm>2.75 mmp-value

Number of patients686552134-117117-

Patients with clinical follow-up604 (88.0%)493 (89.3%)111 (82.8%)0.038106 (90.6%)99 (84.6%)-

Follow-up time (months)8.7±1.78.7±1.78.8±1.70.5238.5±1.88.8±1.80.306

In hospital MACE7 (1.2%)4 (0.8%)3 (2.7%)0.0931 (0.9%3 (3.0%)0.313

In hospital Re-PTCA2 (0.3%)1 (0.2%)1 (0.9%)0.2470 (0.0%)1 (0.9%)0.316

In hospital CABG0 (0.0%)0 (0.0%)0 (0.0%)-0 (0.0%)0 (0.0%)-

In hospital MI5 (0.8%)2 (0.4%)3 (2.7%)0.0161 (0.9%)3 (2.6%)0.313

In hospital cardiac death2 (0.3%)1 (0.2%)1 (0.9%)0.2470 (0.0%)1 (0.9%)0.316

Acute Thrombotic events
 acute (<24h)1 (0.2%)0 (0.0%)1 (1.1%)0.0820 (0.0%)0 (0.0%)-
 subacute (>24h)1 (0.2%)1 (0.2%)0 (0.0%)0 (0.0%)0 (0.0%)

9-month MACE34 (5.6%)27 (5.5%)7 (6.3%)0.7326 (5.7%)6 (6.1%)0.903

9-month TLR14 (2.3%)12 (2.4%2 (1.8%)0.6894 (3.8%)1 (1.0%)0.200

9-month Re-PTCA10 (1.7%)9 (1.8%)1 (0.9%)0.4904 (3.8%)1 (1.0%)0.200

9-month CABG5 (0.8%)4 (0.8%)1 (0.9%)0.9160 (0.0%)0 (0.0%)-

9-month MI22 (3.6%)17 (3.4%)5 (4.5%)0.5923 (2.8%)4 (4.0%)0.624

9-month cardiac death6 (1.0%)3 (0.3%)3 (2.7%)0.0440 (0.0%)3 (3.0%)0.071

9-month TVR25 (4.1%)20 (4.1%)5 (4.5%)0.8318 (7.5%)4 (4.0%)0.285

9-month non-target vessel revascularization14 (2.3%)10 (2.0%)4 (3.6%)0.3192 (1.9%)3 (3.0%)0.596

9-month vessel thrombosis2 (0.3%)1 (0.2%)1 (0.9%)0.2470 (0.0%)1 (1.0%)0.300

DES thrombotic event distal of DCB lesion.
independent t-test, otherwise Chi2 or Fisher’s Exact Test whenever applicable.